Nitric Oxide May Slow Progression of COVID-19

A recent review published by GW researchers suggests that nitric oxide has promise as a therapeutic to control the replication and rapid spread of SARS-CoV-2
George Washington University
21-Jul-2020 11:25 AM EDT, by George Washington University

Newswise — WASHINGTON (July 21, 2020) – Nitric oxide treatment can be pivotal in the world’s fight against SARS-CoV-2, the coronavirus that causes COVID-19, according to a review from the George Washington University (GW). The article is published in the journal Nitric Oxide.

Nitric oxide is an antimicrobial and anti-inflammatory molecule with key roles in pulmonary vascular function in the context of viral infections and other pulmonary diseases. In SARS-CoV-1 infection, which led to the outbreak of SARS (severe acute respiratory syndrome) in 2003, nitric oxide inhibited viral replication by cytotoxic reactions through intermediates such as peroxynitrite. It is one of several potential COVID-19 treatments included in the U.S. Food and Drug Administration’s emergency expanded access program.

“Nitric oxide plays key roles in maintaining normal vascular function and regulating inflammatory cascades that contribute to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS),” said Adam Friedman, MD, interim chair and professor in the Department of Dermatology at the GW School of Medicine and Health Sciences and co-senior author of the review. “Interventions that are protective against ALI and ARDS can play a critical role for patients and health systems during the pandemic.”

Coronaviruses are RNA viruses that primarily infect birds or livestock, but can mutate to be highly infectious and lethal in humans. There is currently no registered treatment or vaccine for COVID-19. The absence of a specific treatment and the high mortality rate of the virus dictate an urgent need for therapeutics that may control the replication and rapid spread of the virus.

The team, led by first author Nagasai Adusumilli, MBA, a fourth-year medical student at the GW School of Medicine and Health Sciences, reviewed data from between 1993 and 2020 on the pathogenesis of coronaviruses and the use of nitric oxide as a treatment for respiratory illness. The authors highlight the potential for inhaled nitric oxide contributing to better clinical outcomes and alleviating the rapidly rising strain on health care capacity due to COVID-19.  

As groups continue to publish more results with their respective nitric oxide platforms, the team recommends that dosing and protocol variations should be examined in evaluating the studies.

“With the emergence of COVID-19 as a pandemic with the ability to overwhelm the body and our health care infrastructure, patients have a pressing need for effective agents that can slow the disease in their bodies and in their communities,” Friedman said.

The authors suggest that if nitric oxide’s efficacy is illustrated for COVID-19, its use as a treatment can be pivotal in the fight against the pandemic.

Friedman has been collaborating with co-senior author Joel Friedman, MD, PhD, professor of physiology and biophysics and of medicine at Albert Einstein College of Medicine, on research related to the use of nitric oxide in a broad range of medical indications for close to two decades, and together are developing nitric oxide-based therapeutics for COVID-19.

“Harnessing nitric oxide for preventing, limiting, and treating the severe pulmonary consequences of COVID-19” can be found at www.sciencedirect.com/science/article/pii/S1089860320301701.

SEE ORIGINAL STUDY




Filters close

Showing results

1120 of 3821
Newswise: UNH Digs Deep Testing Wastewater for Early Warning Signs of COVID-19
Released: 28-Oct-2020 1:05 PM EDT
UNH Digs Deep Testing Wastewater for Early Warning Signs of COVID-19
University of New Hampshire

The University of New Hampshire has gone underground to flush out cases of the coronavirus by testing wastewater on campus. The sewage sampling is being used as a secondary surveillance method to the already required twice a week individual nasal test to track and detect SARS-CoV-2, the virus that causes COVID-19.

Newswise: Safely Celebrate the Holidays During COVID-19
Released: 28-Oct-2020 12:50 PM EDT
Safely Celebrate the Holidays During COVID-19
Rush University Medical Center

Families gathered around the table for hours to share food, conversation and laughter — all the ingredients for a joyous holiday -- and the spread of COVID-19. Rush infectious disease specialists and a child psychologist share facts and tips for enjoying the holidays safely.

Released: 28-Oct-2020 12:45 PM EDT
COVID-19 vaccine nationalism could cost world up to $1.2 trillion: New RAND Europe study
RAND Corporation

Nationalistic behaviour by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research organisation RAND Europe.

Newswise:Video Embedded first-came-breast-cancer-then-covid-19
VIDEO
Released: 28-Oct-2020 12:00 PM EDT
First Came Breast Cancer, Then COVID-19
Cedars-Sinai

Natalie Coehlo wasn’t concerned at first about the sudden rash on her left breast last December. Six months later, though, when the rash had morphed into sores, she visited her primary care physician in Tulare, California.

Newswise: 247119_web.jpg
Released: 28-Oct-2020 11:55 AM EDT
Lockdown interviews show poor housing quality has made life even tougher
University of Huddersfield

Life during COVID-19 has not been a uniform experience. There have been distinct differences in how people have contended with lockdown, depending on whether they have access to safe, secure and decent accommodation.

Released: 28-Oct-2020 11:45 AM EDT
Cognitive disorders linked to severe COVID-19 risk
University of Georgia

Dementia and other cognitive disorders now appear to be risk factors for developing severe COVID-19, according to research from the University of Georgia.

Newswise: University of Miami serving as pilot study site for new, rapid coronavirus breathalyzer test
Released: 28-Oct-2020 11:40 AM EDT
University of Miami serving as pilot study site for new, rapid coronavirus breathalyzer test
University of Miami Health System, Miller School of Medicine

By participating in a short clinical research study that begins this week, the University of Miami became the first college testing site for a quick, easy, and cost-effective Israeli-produced COVID-19 Breath Analyzer that could revolutionize coronavirus testing if approved by the U.S. Food and Drug Administration (FDA).

Newswise: UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug screening
Released: 28-Oct-2020 11:35 AM EDT
UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug screening
University at Buffalo

University at Buffalo spinoff Cytocybernetics is developing a high-tech tool called CyberQ to rapidly assess whether or not investigational COVID-19 drugs have arrhythmogenic properties that can result in sudden cardiac death.

Newswise: Nova Southeastern University Researchers Receive $4 Million From CDC for ‘COVID Long Haulers’ Study
Released: 28-Oct-2020 11:30 AM EDT
Nova Southeastern University Researchers Receive $4 Million From CDC for ‘COVID Long Haulers’ Study
Nova Southeastern University

As the COVID-19 pandemic continues to evolve, health care providers are finding more and more patients are experiencing lingering symptoms after recovering from the virus. While the medical community is still working hard to address the virus itself and racing toward a vaccine, there is very little known or being done to address these residual health issues being experienced by those now called “COVID long haulers.” But all of that is about to change, thanks to research scientists at Nova Southeastern University (NSU.)


Showing results

1120 of 3821

close
1.19189